PFE Pfizer News and press releases

News

Pro users get this 30m faster

10 Health Care Stocks Showing Unusual Options Activity In Today's Session

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.

Why Fauci Thinks Getting Johnson & Johnson COVID-19 Vaccine 'Back On Track' Soon Is Crucial

Biotech, General

White House Chief Medical Advisor Dr. Anthony Fauci believes U.S. regulators will make a quick decision to lift the pause on administering the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine and get the vaccine “back on track.”

UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots

Biotech, News, Health Care, FDA, General

Moderna's COVID-19 Shot Provides Over 90% Effectiveness Six Months After Second Dose, Boosters Can Potentially Fight Against Variants

Biotech, News, Health Care, FDA, General

'Pfizer has ramped up production of our #COVID19 vaccine & can deliver 10% more doses to the US by the end of May than previously agreed (total of 220M) & supply the full 300M agreed on for the end of July two weeks early'

-tweet from company Chair, CEO, Albert Bourla https://twitter.com/AlbertBourla/status/1382064225229619202

FDA, CDC Officials Discuss Johnson & Johnson Vaccine: A 'Pause Recommendation', Resolution Timeline And Advisory

News, Health Care, FDA, Top Stories, General

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) handed down a recommendation to pause the use of Johnson & Johnson's (NYSE:

Why Novavax Stock Is Popping, Despite Vaccine Rollout Issues: Report

Biotech, News, Media

Why Vaccine Stocks Pfizer, BioNTech, Moderna And Novavax Are Higher

News, Health Care, Top Stories, Movers, Trading Ideas, General

Johnson & Johnson's (NYSE: JNJ) pain has proved to be gain for other vaccine companies, including BioNTech SE (NASDAQ: BNTX), Pfizer Inc.

UPDATE: New York Governor Cuomo Says 'All Appointments For Johnson & Johnson Vaccines Today At New York State Mass Vaccination Sights Will Be Honored With Pfizer Vaccine'

https://twitter.com/NYGovCuomo/status/1381954783641210884?s=20

New York Governor Andrew Cuomo Issues Statement On Johnson & Johnson Vaccine

https://twitter.com/NYGovCuomo/status/1381954783641210884

Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Apr. 13, 2021: ZM, AGC, EQOS, WKHS, BTN

Pre-Market Outlook

Today's 5 Stock Ideas: Zoom Video Communications (ZM) - The stock market was impacted Tuesday morning by news the FDA put a pause on administering the Johnson & Johnson (JNJ) COVID-19

South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report

Biotech, Government, News, Health Care, FDA, General

AstraZeneca Farxiga Drug Doesn't Work Against COVID-19

Biotech, News, General

AstraZeneca Plc (NASDAQ: AZN) said Monday its diabetes drug Farxiga failed to achieve the main endpoints in a late-stage trial, dubbed DARE-19, for effectiveness against COVID-19.

6 Pet Stocks And An ETF For National Pet Day

Specialty ETFs, Trading Ideas, ETFs

National Pet Day was created in 2006 to bring awareness to adopting and spoiling pets. The holiday takes place every year on April 11.

European Union Looks To Buy 1.8B Pfizer-BioNTech COVID-19 Vaccine Doses From 2022: Reuters

Biotech, Government, News, Health Care, Contracts, FDA, General

Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report

M&A, News, IPOs

One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public.

J&J Seeks To Conduct Study For COVID-19 Vaccine In India: Reuters

Biotech, Government, News, Health Care, FDA, General

What's Going On With CELC Stock And PRVB Stock Today?

News, Downgrades, Price Target, Small Cap, Analyst Ratings

Celcuity Inc (NASDAQ: CELC) shares are trading higher after the company announced a worldwide licensing agreement with Pfizer Inc. (NYSE: PFE) to develop and commercialize gedatolisib.

Benzinga Pro's Top 5 Stocks To Watch For Friday, Apr. 9, 2021: GS, PFE, GLSI, NAKD, LHDX

Pre-Market Outlook

Today's 5 Stock Ideas: Goldman Sachs (GS) - Will report Q1 results before market open on Wednesday of next week. Pfizer (PFE) - The company will host an analyst and

The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs

Biotech, News, Penny Stocks, Small Cap, FDA, IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8)

Press releases

Pro users get this 30m faster

Thinking about trading options or stock in Apple, Advanced Micro Devices, Nio, Pfizer, or Wells Fargo?

Small Cap, Opinion, Press Releases

NEW YORK, April 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AMD, NIO, PFE, and WFC.

Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22

Pfizer Inc. (NYSE:PFE) announced today that shareholders and the general public are invited to access its virtual-only 2021 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 22, 2021. As previously

Businesses Seek Comprehensive Solutions to Help Curtail the Spread of Diseases

Small Cap, Opinion, Press Releases

NEW YORK, April 15, 2021 /PRNewswire/ -- The pandemic is still a very real threat as the number of new cases spiked in the United States once again. CDC's most recent data shows that the seven-day average of new

Thinking about trading options or stock in Apple, American Airlines, Pfizer, Nio, or General Electric?

Opinion, Press Releases

NEW YORK, April 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AAL, PFE, NIO, and GE. NEW YORK, April 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, AAL, PFE, NIO, and GE.

Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet

Health Care, Press Releases, General

SERENE is a Phase 3 single-arm, open-label study evaluating the contraceptive efficacy of investigational relugolix combination tablet in sexually active, healthy women ages 18-35 yearsContraceptive potential of

Thinking about trading options or stock in Apple, Carnival Corp, Nio, Pfizer, or Snap?

Opinion, Press Releases

NEW YORK, April 9, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, CCL, NIO, PFE, and SNAP.

Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer

-Preliminary data from 103 patients in the expansion portion of a Phase 1b clinical trial demonstrated the drug was well tolerated and anti-tumor activity was noted - Unique opportunity to leverage CELsignia platform

Pharma Companies Seeking to Improve Health Outcomes With Innovative Products

Small Cap, Opinion, Press Releases

NEW YORK, April 8, 2021 /PRNewswire/ -- Conditions such as HIV, asthma, hepatitis, and severe migraines affect the quality of life of those living with these conditions. These conditions require patients to take

Thinking about trading options or stock in Microsoft, Nio, Pfizer, Norwegian Cruise Line, or Draftkings?

Opinion, Press Releases

NEW YORK, April 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MSFT, NIO, PFE, NCLH, and DKNG.

Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority review period for the New Drug Application (NDA) for abrocitinib for the treatment of adults and

Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021

Pfizer Inc. (NYSE:PFE) invites investors and the general public to access a live video webcast of a presentation and conference call with investment analysts at 10 a.m. EDT on Friday, April 9, 2021. Pfizer Oncology

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second

Thinking about trading options or stock in Chewy, Pfizer, Ford, Boeing, or Blink Charging?

Opinion, Press Releases

NEW YORK, March 31, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CHWY, PFE, F, BA, and BLNK.

Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well

Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well

EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union

New stability data show vaccine can be stored at -25°C to -15°C for a total of two weeks and support decentralized distribution plans for vaccination at general practitioners' offices Label update offers greater

Astellas Receives Positive CHMP Opinion for XTANDI™ (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer

TOKYO, March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today the Committee for Medicinal Products for Human Use (CHMP) of the

Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain

Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced the outcome of the U.S. Food and Drug Administration (FDA) Joint Arthritis Advisory Committee and Drug Safety and Risk Management Advisory

Real-World Evidence Supports Effectiveness of First-line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer

First large-scale comparative effectiveness analysis of a CDK 4/6 inhibitor plus letrozole evaluating progression-free and overall survival versus letrozole alone Pfizer Inc. (NYSE:PFE) today announced the